How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area

<div>Graphical representation of the representativeness of patients in SGLT2i CVOTs when compared to the general type 2 diabetes population from four European countries, the US, and the present Mediterranean population.</div>

Journal of Diabetes Research

fig1

Figure 1

Figure 1: How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area 

Figure 1 | How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area 